Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is BeiGene Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate 16.19% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -83.25
2
The company has declared negative results in Dec'2023 after 4 consecutive positive quarters
- PBT LESS OI(Q) At HKD -3,036 MM has Fallen at -17.0 %
- PAT(Q) At HKD -2,914 MM has Fallen at -53.0 %
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 75.23%, its profits have risen by 74.3%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is BeiGene Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
BeiGene Ltd.
78.93%
1.98
52.44%
Hang Seng Hong Kong
27.36%
1.03
25.88%
Quality key factors
Factor
Value
Sales Growth (5y)
79.78%
EBIT Growth (5y)
16.19%
EBIT to Interest (avg)
-83.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
0.27
Tax Ratio
45.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.86
EV to EBIT
-316.93
EV to EBITDA
356.28
EV to Capital Employed
16.05
EV to Sales
6.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.06%
ROE (Latest)
-4.24%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for BeiGene Ltd.
Net Sales - Half Yearly
At HKD 11,070.54 MM has Grown at 84.04 %
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Operating Cash Flow - Annually
Highest at HKD -9,061.63 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Here's what is not working for BeiGene Ltd.
Profit Before Tax less Other Income (PBT) - Quarterly
At HKD -3,036 MM has Fallen at -17.0 %
over average PBT of the previous four periods of HKD -2,594 MMMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (HKD MM)
Profit After Tax (PAT) - Quarterly
At HKD -2,914 MM has Fallen at -53.0 %
over average PAT of the previous four periods of HKD -1,905 MMMOJO Watch
Near term PAT trend is very negative
PAT (HKD MM)






